Open AccessAngiotensin II receptor type 1 blocker candesartan improves morphine tolerance by reducing morphine‑induced inflammatory response and cellular activation of BV2 cells via the PPARγ/AMPK signaling pathway
Author(s) -
W. R. Zhao,
Feiyan Shen,
Jixiang Yao,
Shanshan Su,
Zhuanjun Zhao
Publication year - 2022
Publication title -
molecular medicine reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.727
H-Index - 56
eISSN - 1791-3004
pISSN - 1791-2997
DOI - 10.3892/mmr.2022.12834
Subject(s) - candesartan , angiotensin ii , blot , pharmacology , peroxisome proliferator activated receptor , signal transduction , angiotensin receptor , ampk , receptor , chemistry , endocrinology , medicine , protein kinase a , biology , microbiology and biotechnology , kinase , biochemistry , gene